The impact of interferon-β treatment on the blood–brain barrier
- 31 August 2006
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 11 (15-16), 755-762
- https://doi.org/10.1016/j.drudis.2006.06.008
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelinesProceedings of the National Academy of Sciences of the United States of America, 2004
- Interferon (IFN)-ß1a and IFN-ß1b Block IFN-?-Induced Disintegration of Endothelial Junction Integrity and BarrierEndothelium, 2003
- A Controlled Trial of Natalizumab for Relapsing Multiple SclerosisNew England Journal of Medicine, 2003
- Regulation of Th1 and Th2 Lymphocyte Migration by Human Adult Brain Endothelial CellsJournal of Neuropathology and Experimental Neurology, 2001
- Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapyTrends in Molecular Medicine, 2001
- Multiple SclerosisNew England Journal of Medicine, 2000
- Serial magnetization transfer imaging to characterize the early evolution of new MS lesionsNeurology, 1998
- Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesionsActa Neuropathologica, 1997
- Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Stereotactic Biopsy of an Active Multiple Sclerosis LesionArchives of Neurology, 1990